CRYO-CELL International Inc. Registered Shares DL -,01
- BID
2.82
- ASK
3.6
- 1,418 Units1,113 Units
- 07/21, 16:37:00 PM
Sector and Industry
Healthcare, Healthcare Services
Performance (1Y)
28.22%
Market Cap
-
P/E Ratio
0.00
Dividend Yield
9.30 %
Earnings per Share
-0.27 €
Peer Group
| Company Name | Market Cap | Revenue Last Reported Year | P/E Ratio | Profit Growth 1Y | Last Price | Previous Trading Day Change |
|---|---|---|---|---|---|---|
| UnitedHealth Group Inc. | 254.66 Bil. | 396.73 Bil. | 24.94 | -19.75 % | 0.00 | - |
| Thermo Fisher Scientific Inc. | 185.62 Bil. | 39.50 Bil. | 32.67 | +1.45 % | 0.00 | - |
| Danaher Corp. | 137.79 Bil. | 21.78 Bil. | 45.36 | -11.47 % | 0.00 | - |
| McKesson Corporation | 90.13 Bil. | 348.09 Bil. | 22.55 | +33.83 % | 0.00 | - |
| HCA Healthcare Inc. | 89.28 Bil. | 67.01 Bil. | 16.48 | +12.93 % | 0.00 | - |
| Elevance Health Inc. | 65.88 Bil. | 176.51 Bil. | 13.91 | -9.22 % | 0.00 | - |
| The Cigna Group | 61.74 Bil. | 243.65 Bil. | 12.41 | +66.33 % | 0.00 | - |
| Cencora Inc. | 51.58 Bil. | 291.15 Bil. | 39.26 | +1.16 % | 0.00 | - |
| IDEXX Laboratories Inc. | 45.92 Bil. | 3.81 Bil. | 51.74 | +14.41 % | 0.00 | - |
| Zoetis Inc. | 45.52 Bil. | 8.39 Bil. | 20.89 | +3.10 % | 0.00 | - |
Facts & figures
Price data
| TRADE PLATFORM | Börse Stuttgart (XSTU) | |
| LAST PRICE | 2.82 G | 0 Units |
| PRICE DETERMINATION TIME | 07/21/2026 / 04:33:36 PM | |
| DAILY VOLUME (UNITS) | 0 | |
| DAILY HIGH / LOW | 2.88 | 2.8 |
| PREV. DAY'S PRICE | 2.9 | (07/20) |
| CHANGE DAY BEFORE | -0.08 | -2.76 % |
| 52 WEEK HIGH / LOW | 4.46 (07/23) | 2.32 (03/16) |
Key Figures (in EUR)
| 2023 | 2024 | 2025 | 2026e | 2027e | |
|---|---|---|---|---|---|
EARNINGS PER SHARE | -1.06 | 0.05 | -0.27 | 0.10 | 0.02 |
DIVIDENDS PER SHARE | 0.00 | 0.23 | 0.36 | - | - |
DIVIDEND YIELD IN % | 0.00 % | 2.88 % | 9.30 % | - | - |
DIVIDEND GROWTH IN % | -100.00 % | - | 55.45 % | - | - |
PRICE - EARNINGS RATIO | - | 176.94 | - | 31.45 | 173.00 |
PRICE - BOOK RATIO | - | - | - | - | - |
PRICE - SALES RATIO | 1.42 | 2.23 | 1.10 | - | - |
PRICE - CASH FLOW RATIO | 5.00 | 11.85 | 6.33 | - | - |
Master Data
| WKN | 923368 |
| ISIN | US2288951088 |
| SYMBOL | ZCY |
| EXCHANGE SEGMENT | Freiverkehr |
| TYPE OF FINANCIAL INSTRUMENT | Equity |
| DENOMINATION | CRYO-CELL INTL DL-,01 |
| INDEX MEMBERSHIP | - |
| TRADING SEGMENT | - |
| TRADING HOURS | 07:30:00 AM - 10:00:00 PM |
| TRADING CURRENCY | Euro |
| NOMINAL CURRENCY | - |
| SETTLEMENT CURRENCY | Euro |
| SECTOR AND INDUSTRY | Healthcare, Healthcare Services |
| NUMBER OF SHARES | - |
| MARKET CAPITALISATION | - |
Performance overview
| 1W | 1M | 3M | 6M | 1Y | 3Y | 5Y | YTD | |
|---|---|---|---|---|---|---|---|---|
| PERFORMANCE | 4.32 % | -11.59 % | -0.68 % | 3.57 % | -28.22 % | - | - | 2.11 % |
| HIGH | 3.02 | 3.28 | 3.28 | 3.28 | 4.46 | - | - | 3.28 |
| LOW | 2.76 | 2.36 | 2.36 | 2.32 | 2.32 | - | - | 2.32 |
Dividende
pro Aktie
Company profile
Cryo-Cell International, Inc. is a cord blood bank, which engages in providing stem cell cryopreservation services and advancing regenerative medicine. It operates through the following segments: Umbilical Cord Blood and Cord Tissue Stem Cell Service, PrepaCyte CB, and Public Cord Blood Banking. The Umbilical Cord Blood and Cord Tissue Stem Cell Service segment refers to cellular processing and cryogenic storage of umbilical cord blood and cord tissue stem cells for family use. The PrepaCyte CB segment focuses on the manufacture of PrepaCyte CB units, the processing technology used to process umbilical cord blood stem cells. The Public Cord Blood Banking segment relates to the cellular processing and cryogenic storage of umbilical cord blood stem cells for public use. The company was founded in 1989 and is headquartered in Oldsmar, FL.
Analyst Rating
Ø-Target Price DistanceNot Available
Current Price
Not AvailableØ-Target Price
Not AvailableAverage ResultNot Available
Buy0
Overweight0
Hold0
Underweight 0
Sell0
Company Events
No company events available.